CS
SQZ

Credit Suisse’s SQZ Biotechnologies Company SQZ Stock Holding History

Credit Suisse’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12
Closed – – 4450
2022
Q2 		$0 Buy
+12
New +$43 ﹤0.01% 4516

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse's SQZ Position: Q3 2022 in Review

Credit Suisse sold out of SQZ Biotechnologies Company (SQZ) in Q3 2022, closing a stake of 12 shares.

Credit Suisse first reported a position in SQZ in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 48 funds tracked by Wall St. Rank hold SQZ as of Q3 2022.

  • Credit Suisse reported no remaining SQZ Biotechnologies Company position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 12 SQZ Biotechnologies Company shares in Q3 2022.
  • Credit Suisse first reported a position in SQZ Biotechnologies Company in Q2 2022 and held it in 1 quarter.
  • Credit Suisse's SQZ Biotechnologies Company position peaked at $0 in Q2 2022.
  • 48 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.